Recently Launched!
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos

[SRPT] Sarepta Therapeutics Inc - Time Machine

Data updated 2025-Apr-07 (Monday)

 


Quick Instructional video for this page. Collapse this after viewing by clicking How-to button above. Open in new tab 

Youtube Thumbnail



Note: Historical Detail for Sarepta Therapeutics Inc as of 2025-Apr-07 (about 2 months ago) Market Close includes Performance (day & prior periods), Technical Indicators and Benchmarks. Use Related Links to view other info such as historical Financials and News for [NASDAQ:SRPT] as available

Share       
Other Dates:  
Time machine widget shows Historical Detail for Sarepta Therapeutics Inc on other dates (from 1998-Jan-02)
Historical Summary: 2025-Apr-07 Monday
 Open $51.59   High $55.17 +6.94%
 Close $52.40   Low $50.61 -1.90%
Volume 4.16 Million 1.34x Volatility 9.01%
Change $-2.03 -3.73%
Streak ↓ 3 days -16.12%

 20d SMA $75.86 -30.9%  50d SMA $95.84 -45.3%  100d SMA $108.33 -51.6%  200d SMA $121.88 -57.0%
 RSI 19  MACD -1.55  ADX 54.4  Stochastic Oscillator 3.2 2.9
 CCI -132.2  ATR 4.97  OBV 267 Million  Chaikin A/D -548 Thousand
 
Health Care Biotechnology

Anomalies  AI

Anomaly Detection for Sarepta Therapeutics Inc looks at key performance metrics relative to it's history (upto 10 years) for Sarepta Therapeutics Inc to identify unusual levels for 2025-Apr-07:

  • 50-d Downswing at +3.5% is extraordinarily low. Subsequent performance over next 20 days in such cases averages +11.1% and is up 71% of the time. Subsequent performance over next 50 days in such cases averages +21.2% and is up 74% of the time
  • 20-day Relative Volume at 1.2x is abnormally elevated
  • 100-d Upswing at -62.3% is extraordinarily low. Subsequent performance over next 20 days in such cases averages +28.8% and is up 75% of the time. Subsequent performance over next 100 days in such cases averages +228.7% and is up 98% of the time
  • Intraday Upswing at +6.9% is unusually high
  • 20-d Performance at -47.4% is extremely low
  • ...
    Sign Up or Login to see more performance anomalies

    Anomaly Detection for Sarepta Therapeutics Inc looks at key technical metrics relative to it's history (upto 10 years) for Sarepta Therapeutics Inc to identify unusual levels for 2025-Apr-07:

  • ADX at 54.4 is extremely elevated
  • % off 50d EMA at -42.0% is extraordinarily depressed. Subsequent performance over next 20 days in such cases averages +18.8% and is up 88% of the time. Subsequent performance over next 100 days in such cases averages +93.9% and is up 77% of the time
  • CCI at -132.2 is extraordinarily depressed. Subsequent performance over next 50 days in such cases averages +15.3% and is up 68% of the time
  • % off 50d SMA at -45.3% is extraordinarily depressed. Subsequent performance over next 20 days in such cases averages +14.4% and is up 76% of the time. Subsequent performance over next 100 days in such cases averages +103.9% and is up 76% of the time
  • MACD at -12.2 is extremely depressed. Subsequent performance over next 100 days in such cases averages +20.0% and is up 70% of the time
  • ...
    Sign Up or Login to see more performance anomalies

     Anomaly Details



    Choose view type


    Monthly Performance for Sarepta Therapeutics Inc. Click on candlesticks in Chart to show/hide summary for day or navigate to historical record (Time Machine functionality)


    Max Chart Timespan

    Note: Performance over Key Timeperiods for Sarepta Therapeutics Inc up to close of 2025-Apr-07 at $52.40
    Performance Benchmarks from 2025-Apr-07 for Sarepta Therapeutics Inc:



    Related to Sarepta Therapeutics Inc

    Information for Sarepta Therapeutics Inc

      Current Detail : Recent daily/monthly performance & benchmark comparison
      Historical Detail : Historical performance & related information using Time Machine Currently Viewing
      Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers
      Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
      Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
      Historical Seasonality : Seasonal performance by calendar months
      Technical History : Popular Technical indicator trends (RSI, MACD etc.)
      Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets
      Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
      Moving Averages : Key Simple & Exponential Moving Averages
      Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
      Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
      News Stories : News stories on 2025-Apr-07 on Google
      SEC Reports : Quarterly reports around 2025-Apr-07 on SEC Edgar

    Compare Sarepta Therapeutics Inc with other assets

      Market Performance : Recent performance across covered assets
      Historical Performance : Prior & Subsequent performance across assets on a historical date
      Market Technicals : Technical indicator levels across covered assets
      Market Seasonality : Seasonal performance by calendar months across covered assets
      Pair Correlations : Performance Correlations with other assets
      Beta : Volatility relative to the broad market
      Performance Comparison : Visually compare/benchmark performance with other assets over time
      Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
      Sector : Health Care sector performance which includes Sarepta Therapeutics Inc
      Industry : Biotechnology industry performance which includes Sarepta Therapeutics Inc